인도네시아 재택 테스트 키트 시장 – 2029년까지의 업계 동향 및 예측

TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

인도네시아 재택 테스트 키트 시장 – 2029년까지의 업계 동향 및 예측

  • Pharmaceutical
  • Published Report
  • Apr 2022
  • Country Level
  • 350 Pages
  • 테이블 수: 69
  • 그림 수: 42

인도네시아 가정용 검사 키트 시장, 검사 유형별(임신 검사 키트, 기타 가정용 검사 키트, 마약 검사 키트, HIV 검사 키트 및 임신 능력 검사 키트), 사용자 유형(상류층, 중산층 및 하류층), 구매자 유형(임신 검사 키트, 기타 가정용 검사 키트, 마약 검사 키트, HIV 검사 키트 및 임신 능력 검사 키트), 공정 위치(가정용 및 가정용 실험실 검사(디지털 결과), 연령(성인, 노인 및 소아), 브랜드(임신 검사, 기타 가정용 검사, 마약 검사, HIV 검사 및 임신 능력 검사), 유통 채널(기관 구매자 및 소매/브랜드 판매) 산업 동향 및 2029년까지의 예측.

 인도네시아 시장 분석 및 통찰력 

재택 검사 키트는 사람이 집에서 검사를 수행하고 1분 안에 빠른 결과를 제공하는 데 도움이 되는 검사 도구를 의미합니다. 또한 당뇨병 환자의 건강을 지속적으로 확인하고 관리하는 건강 모니터링 장비도 포함되어 있습니다. 재택 검사는 집에서 편안하게 수행하기 매우 편리하며 매우 저렴한 가격으로 제공됩니다.

인도네시아 재택 테스트 키트 시장

자가 검사는 일반적으로 원래 의료 전문가를 위해 설계되었으며 일반인이 수행할 수 있는 신속한 진료소 검사 키트의 고급 버전입니다. 검사 절차, 포장 및 지침이 간소화되어 검사 단계를 안내합니다. HIV 검사, 임신 검사, 당뇨병, 배란 검사 및 말라리아, COVID-19 등과 같은 감염성 질환을 포함한 다양한 가정용 검사 키트가 제공됩니다. 이러한 신속한 가정용 검사를 수행하기 위해 혈액, 소변 및 구강액을 샘플로 채취할 수 있습니다.

인도네시아 재택 검사 키트 시장은 2022년부터 2029년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2022년부터 2029년까지의 예측 기간 동안 4.6%의 CAGR로 성장하고 있으며 2021년의 10,13,289.31백만 IDR에서 2029년까지 16,81,367.36백만 IDR에 도달할 것으로 예상된다고 분석했습니다.

보고서 메트릭

세부

예측 기간

2022년부터 2029년까지

기준 연도

2021

역사적 연도

2020

양적 단위

수익(IDR 백만)

다루는 세그먼트

테스트 유형별(임신 테스트 키트, 기타 가정용 테스트 키트, 마약 테스트 키트, HIV 테스트 키트 및 생식력 테스트 키트), 사용자 유형(상류층, 중류층 및 하류층), 구매자 유형(임신 테스트 키트, 기타 가정용 테스트 키트, 마약 테스트 키트, HIV 테스트 키트 및 생식력 테스트 키트), 프로세스 위치(가정용 및 가정용 실험실 테스트(디지털 결과), 연령(성인, 노인 및 소아), 브랜드(임신 테스트, 기타 가정용 테스트, 마약 테스트, HIV 테스트 및 생식력 테스트), 유통 채널(기관 구매자 및 소매/브랜드 판매)

적용 국가

인도네시아 공화국

시장 참여자 포함

The major companies which are dealing in the market are Abbott, PT. Danpac Pharma, Orient Gene, Siemens Healthcare GmbH, Medtronic, BD, B. Braun Melsungen AG, Quidel Corporation, NIPRO, F. Hoffmann-La Roche Ltd., bioMérieux SA, EGENS GROUP, DKT INTERNATIONAL, Clearblue (A subsidiary of SPD Swiss Precision Diagnostics GmbH) and ACON Laboratories, Inc. among others

At-home Testing Kits Market Dynamics

Drivers

  • Growing adoption of self-testing kits

As awareness has grown regarding several products, this behaviour has changed and has turned the trend. Nowadays, people prefer to get their basic tests done using test kits at home before visiting a doctor. This has become even more prominent due to this pandemic as people are adopting more self-help testing kits due to several restrictions in place. It has turned out to be a boon in disguise for both hospitals as patients as hospitals are already stretched thin and can fully focus on COVID-19 patients, and the patients can save hefty costs of doctor visits and medicine fees. It has become extremely convenient for consumers as they can know the results of their tests quickly just at their fingertips.

  • Easy availability of self-testing kits at pharmacies

At-home or self-testing kits are easily available at pharmacies, and it has become extremely easy to procure them. Various medical companies are venturing into this space as they rapidly manufacture self-test kits. This widespread availability can also be attributed to online pharmacies' medical start-ups, making availability easier by clicking a button. In addition, these self-testing kits are available without any prescription

  • Increasing prevalence of chronic diseases

The prevalence of the chronic disease is briskly increasing across the globe. According to the Indonesian Sample Registration System, the ten most common diseases found in Indonesia in 2014 were stroke (21.1%), heart disease (12.9%), diabetes mellitus (6.7%), tuberculosis (5.7%), complications of high blood pressure (5.3%), chronic lung disease (4.9%), liver disease (2.7%), traffic accidents (2.6%), pneumonia (2.1%), and combined diarrhoea and gastroenteritis due to infection (1.9%). Thus, the high prevalence of chronic diseases will be a major driver for the at-home testing kits market as it can provide better monitoring and diagnosis of disease

Opportunities

  • Advent of advanced technologies

The technological experts are continuously working towards the advancements of the rapid testing kits to deliver accurate and reliable results to the person who is not a healthcare professional and can understand the results independently.

Thus, advanced technologies such as artificial intelligence are creating lucrative opportunities for the healthcare industry, the companies are incorporating advanced technologies in at-home testing kits to make them more reliable and trustworthy to drive the market

Also, the strategic initiatives taken by key market players will provide structural integrity and future opportunities for the at-home testing kits market in the forecast period of 2022-2029.

인도네시아 재택 테스트 키트 시장

Restraints/Challenges

However, the inaccuracy of result with self-testing kits will impede the growth rate of at-home testing kits market. Additionally, stringent rules and regulations will further challenge the market in the forecast period mentioned above.

This at-home testing kits market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on at-home testing kits market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post COVID-19 Impact on At-Home Testing Kits Market

The COVID-19 has positively affected the market. Lockdowns and isolation during pandemics complicate the disease management and medication adherence. Hence the use of self-testing kits at households widely increased in the country population. People on large scale used the self-testing kits in the overall pandemic for the disease diagnosis and easy availability of such testing kits boost the market in positive way

Recent Development

  • In November 2020, Quidel Corporation has developed a rapid diagnostic test for the detection of COVID-19 and received Emergency Use Authorization (EUA) from the FDA for launching and marketing its Sofia 2 SARS Antigen FIA, a rapid point-of-care test for COVID-19. It will be used for ongoing pandemic and this will help the company to increase its sales and revenue

Indonesia At-home Testing Kits Market Scope

Indonesia at-home testing kits market is segmented into test type, type of user, type of buyer, process location, age, brands and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Test Type

  • Pregnancy Test Kits
  • Other At-Home Test Kits
  • Narcotic Test Kits
  • HIV Test Kits
  • Fertility Test Kits

On the basis of test type, the Indonesia at-home testing kits market is segmented into pregnancy test kits, other at-home test kits, narcotic test kits, HIV test kits and fertility test kits

Type of User

  • High Class
  • Middle Class
  • Lower Class

On the basis of type of user, the Indonesia at-home testing kits market is segmented into high class, middle class and lower class

Type of Buyer

  • Pregnancy Test Kits
  • Other At-Home Test Kits
  • Narcotic Test Kits
  • HIV Test Kits
  • Fertility Test Kits

구매자 유형을 기준으로 인도네시아 가정용 테스트 키트 시장은 임신 테스트 키트, 기타 가정용 테스트 키트, 마약 테스트 키트, HIV 테스트 키트 및 생식력 테스트 키트로 구분됩니다.

프로세스 위치

  • 집에서
  • 재택 실험실 테스트(디지털 결과)

프로세스 위치를 기준으로 인도네시아 재택 테스트 키트 시장은 재택 및 재택 실험실 테스트(디지털 결과)로 세분화됩니다.

나이

  • 성인
  • 노인
  • 소아과

연령을 기준으로 인도네시아 재택 검사 키트 시장은 성인, 노인 및 소아로 구분됩니다.

브랜드

  • 임신 테스트
  • 기타 재택 테스트
  • 마약 테스트
  • HIV 검사
  • 생식력 검사

브랜드 기준으로 인도네시아 가정용 테스트 키트 시장은 임신 테스트, 기타 가정용 테스트, 마약 테스트, HIV 테스트 및 불임 테스트로 구분됩니다.

유통 채널

  • 기관 구매자
  • 소매/브랜드 판매

인도네시아 재택 테스트 키트 시장

유통 채널을 기준으로 인도네시아 재택 테스트 키트 시장은 기관 구매자와 소매/브랜드 판매로 세분화됩니다.

재택 테스트 키트 시장 지역 분석/통찰력         

가정용 검사 키트 시장을 분석하고, 위에 언급된 대로 국가, 검사 유형, 사용자 유형, 구매자 유형, 프로세스 위치, 연령, 브랜드 및 유통 채널별로 시장 규모에 대한 통찰력과 추세를 제공합니다.

인도네시아는 시장 점유율과 시장 수익 측면에서 가정용 검사 키트 시장을 지배하고 있으며 예측 기간 동안 지배력을 계속 확대할 것입니다. 이는 인도네시아 지역에서 자가 검사 키트에 대한 인식 프로그램과 검사 키트를 위한 첨단 기술 연구 개발을 시행함으로써 이 시장 성장이 더욱 개선되기 때문입니다.

보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규정의 변화를 제공합니다. 신규 및 교체 판매, 국가 인구 통계, 질병 역학 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 글로벌 브랜드의 존재 및 가용성과 국내 및 국내 브랜드와의 치열한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 재택 테스트 키트 시장 점유율 분석

가정용 검사 키트 시장 경쟁 구도는 경쟁업체의 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 위에 제공된 데이터 포인트는 가정용 검사 키트 시장에 대한 회사의 초점과만 관련이 있습니다.

가정용 검사 키트 시장에서 활동하는 주요 기업으로는 Abbott, PT. Danpac Pharma, Orient Gene, Siemens Healthcare GmbH, Medtronic, BD, B. Braun Melsungen AG, Quidel Corporation, NIPRO, F. Hoffmann-La Roche Ltd., bioMérieux SA, EGENS GROUP, DKT INTERNATIONAL, Clearblue(SPD Swiss Precision Diagnostics GmbH의 자회사), ACON Laboratories, Inc. 등이 있습니다.

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석 및 추정됩니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 기본(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 이 외에도 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 추가 문의 사항이 있는 경우 분석가 전화를 요청하십시오.

 


SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF INDONESIA AT-HOME TESTING KITS MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET TYPE OF BUYER COVERAGE GRID

2.8 TEST TYPE LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER'S FIVE FORCES

4.3 MARKET SHARE BY PLAYERS

4.3.1 INDONESIA AT-HOME TESTING KITS MARKET SIZE AND SHARE, BY PLAYERS (IDR MILLION, 2021)

4.3.2 INDONESIA AT-HOME TESTING KITS MARKET SIZE AND SHARE, BY PLAYERS (IDR MILLION, 2022)

4.3.3 INDONESIA AT-HOME TESTING KITS MARKET SIZE AND SHARE, BY PLAYERS (IDR MILLION, 2023)

4.3.4 INDONESIA AT-HOME TESTING KITS MARKET SIZE AND SHARE, BY PLAYERS (IDR MILLION, 2024)

4.3.5 INDONESIA AT-HOME TESTING KITS MARKET SIZE AND SHARE, BY PLAYERS (IDR MILLION, 2025)

4.3.6 INDONESIA AT-HOME TESTING KITS MARKET SIZE AND SHARE, BY PLAYERS (IDR MILLION, 2026)

5 INDONESIA AT- HOME TESTING KITS MARKET: REGULATIONS

5.1 REGULATION IN INDONESIA:

6 SUMMARY WRITE UP (INDONESIA)

6.1 OVERVIEW

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 GROWING ADOPTION OF SELF-TESTING KITS

7.1.2 EASY AVAILABILITY OF SELF-TESTING KITS AT PHARMACIES

7.1.3 INCREASE IN AWARENESS ABOUT THE IMPORTANCE OF HIV DIAGNOSIS

7.1.4 INCREASING PREVALENCE OF CHRONIC DISEASES

7.2 RESTRAINTS

7.2.1 INACCURACY OF RESULTS BY SELF-TESTING KITS

7.2.2 STRINGENT GOVERNMENT REGULATIONS FOR MANUFACTURING AND DISTRIBUTION OF TESTING KITS

7.3 OPPORTUNITIES

7.3.1 ADVENT OF ADVANCED TECHNOLOGIES

7.3.2 EMERGING NEED FOR RAPID TESTING KITS FOR COVID-19 PANDEMIC

7.3.3 STRATEGIC INITIATIVES OF KEY PLAYERS

7.4 CHALLENGES

7.4.1 HIGH COMPETITION IN MEDICAL TECHNOLOGY INDUSTRY

7.4.2 REDUCTION IN RESEARCH & DEVELOPMENT BUDGETS

8 INDONESIA AT-HOME TESTING KITS MARKET, BY TEST TYPE

8.1 OVERVIEW

8.2 PREGNANCY TEST KITS

8.2.1 STRIP

8.2.2 MIDSTREAM

8.2.3 CASSETTE

8.2.4 DIP CARD

8.2.5 TEST PANEL

8.2.6 OTHERS

8.3 NARCOTIC TEST KITS

8.3.1 CASSETTE

8.3.2 DIP CARD

8.3.3 TEST PANEL

8.3.4 STRIP

8.3.5 MIDSTREAM

8.3.6 OTHERS

8.4 HIV TEST KITS

8.4.1 STRIP

8.4.2 CASSETTE

8.4.3 TEST PANEL

8.4.4 DIP CARD

8.4.5 MIDSTREAM

8.4.6 OTHERS

8.5 FERTILITY TEST KITS

8.5.1 STRIP

8.5.2 MIDSTREAM

8.5.3 CASSETTE

8.5.4 DIP CARD

8.5.5 TEST PANEL

8.5.6 OTHERS

8.6 OTHER AT-HOME TEST KITS

8.6.1 GLUCOSE TESTS

8.6.2 INFECTIOUS DISEASES TESTS

8.6.3 OTHERS

9 INDONESIA AT-HOME TESTING KITS MARKET, BY TYPE OF USER

9.1 OVERVIEW

9.2 MIDDLE CLASS

9.2.1 PREGNANCY TEST KITS

9.2.2 NARCOTIC TEST KITS

9.2.3 HIV TEST KITS

9.2.4 FERTILITY TEST KITS

9.2.5 OTHER AT-HOME TEST KITS

9.3 HIGH CLASS

9.3.1 PREGNANCY TEST KITS

9.3.2 NARCOTIC TEST KITS

9.3.3 HIV TEST KITS

9.3.4 FERTILITY TEST KITS

9.3.5 OTHER AT-HOME TEST KITS

9.4 LOW CLASS

9.4.1 PREGNANCY TEST KITS

9.4.2 NARCOTIC TEST KITS

9.4.3 HIV TEST KITS

9.4.4 FERTILITY TEST KITS

9.4.5 OTHER AT-HOME TEST KITS

10 INDONESIA AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER

10.1 OVERVIEW

10.2 PREGNANCY TEST KITS

10.2.1 GOVERNMENT/INSTITUTIONAL

10.2.1.1 HOSPITAL

10.2.1.2 PUBLIC HEALTH CENTER

10.2.1.3 NON-GOVERNMENT ORGANIZATION

10.2.2 RETAIL/BRANDED

10.2.2.1 RETAIL PHARMACIES

10.2.2.2 ONLINE PHARMACIES

10.2.2.3 DRUG STORE

10.2.2.4 SUPERMARKET/HYPERMARKET

10.3 NARCOTIC TEST KITS

10.3.1 GOVERNMENT/INSTITUTIONAL

10.3.1.1 HOSPITAL

10.3.1.2 PUBLIC HEALTH CENTER

10.3.1.3 NON-GOVERNMENT ORGANIZATION

10.3.2 RETAIL/BRANDED

10.3.2.1 RETAIL PHARMACIES

10.3.2.2 ONLINE PHARMACIES

10.3.2.3 DRUG STORE

10.3.2.4 SUPERMARKET/HYPERMARKET

10.4 HIV TEST KITS

10.4.1 GOVERNMENT/INSTITUTIONAL

10.4.1.1 HOSPITAL

10.4.1.2 PUBLIC HEALTH CENTER

10.4.1.3 NON-GOVERNMENT ORGANIZATION

10.4.2 RETAIL/BRANDED

10.4.2.1 RETAIL PHARMACIES

10.4.2.2 ONLINE PHARMACIES

10.4.2.3 DRUG STORE

10.4.2.4 SUPERMARKET/HYPERMARKET

10.5 FERTILITY TEST KITS

10.5.1 GOVERNMENT/INSTITUTIONAL

10.5.1.1 HOSPITAL

10.5.1.2 PUBLIC HEALTH CENTER

10.5.1.3 NON-GOVERNMENT ORGANIZATION

10.5.2 RETAIL/BRANDED

10.5.2.1 RETAIL PHARMACIES

10.5.2.2 ONLINE PHARMACIES

10.5.2.3 DRUG STORE

10.5.2.4 SUPERMARKET/HYPERMARKET

10.6 OTHER AT-HOME TEST KITS

10.6.1 GOVERNMENT/INSTITUTIONAL

10.6.1.1 HOSPITAL

10.6.1.2 PUBLIC HEALTH CENTER

10.6.1.3 NON-GOVERNMENT ORGANIZATION

10.6.2 RETAIL/BRANDED

10.6.2.1 RETAIL PHARMACIES

10.6.2.2 ONLINE PHARMACIES

10.6.2.3 DRUG STORE

10.6.2.4 SUPERMARKET/HYPERMARKET

11 INDONESIA AT-HOME TESTING KITS MARKET, BY PROCESS LOCATION

11.1 OVERVIEW

11.2 AT-HOME

11.3 AT-HOME LAB TESTS (DIGITAL RESULT)

11.3.1 VIA E-MAILS

11.3.2 DIRECT COLLECTION OF THE REPORT FROM THE LAB

11.3.3 VIA SHORT MESSAGE SERVICE (SMS)

11.3.4 REPORT GENERATION ON MOBILE APP

11.3.5 OTHERS

12 INDONESIA AT-HOME TESTING KITS MARKET, BY AGE

12.1 OVERVIEW

12.2 ADULT

12.2.1 AT-HOME

12.2.2 AT-HOME LAB TEST (DIGITAL RESULT)

12.3 GERIATRIC

12.3.1 AT-HOME

12.3.2 AT-HOME LAB TEST (DIGITAL RESULT)

12.4 PEDIATRIC

12.4.1 AT-HOME

12.4.2 AT-HOME LAB TEST (DIGITAL RESULT)

13 INDONESIA AT-HOME TESTING KITS MARKET, BY BRANDS

13.1 OVERVIEW

13.2 PREGNANCY TEST

13.2.1 SENSITIF

13.2.2 AKURAT

13.2.3 ANDALAN

13.2.4 BLUEONE

13.2.5 OTHERS

13.3 NARCOTIC TEST

13.3.1 NARCOTEST

13.3.2 ORIENT GENE

13.3.3 EGENS

13.3.4 OTHERS

13.4 HIV TEST

13.4.1 ONE STEP

13.4.2 ORIENT GENE

13.4.3 STANDA REAGEN

13.4.4 OTHERS

13.5 FERTILITY TEST

13.5.1 OVUTEST

13.5.2 CLEARBLUE

13.5.3 ANDALAN

13.5.4 ELHA

13.5.5 OTHERS

13.6 OTHER AT-HOME TEST

14 INDONESIA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL

14.1 OVERVIEW

14.2 INSTITUTIONAL BUYER

14.2.1 HOSPITAL

14.2.2 PUBLIC HEALTH CENTER

14.2.3 NON- GOVERNMENT ORGANIZATION

14.3 RETAILS/ BRANDED SALES

14.3.1 RETAIL PHARMACIES

14.3.1.1 PREGNANCY TEST KITS

14.3.1.2 NARCOTIC TEST KITS

14.3.1.3 HIV TEST KITS

14.3.1.4 FERTILITY TEST KITS

14.3.1.5 OTHER AT-HOME TEST KITS

14.3.2 ONLINE PHARMACIES

14.3.2.1 PREGNANCY TEST KITS

14.3.2.2 NARCOTIC TEST KITS

14.3.2.3 HIV TEST KITS

14.3.2.4 FERTILITY TEST KITS

14.3.2.5 OTHER AT-HOME TEST KITS

14.3.3 DRUG STORE

14.3.3.1 PREGNANCY TEST KITS

14.3.3.2 NARCOTIC TEST KITS

14.3.3.3 HIV TEST KITS

14.3.3.4 FERTILITY TEST KITS

14.3.3.5 OTHER AT-HOME TEST KITS

14.3.4 SUPERMARKET/HYPERMARKET

14.3.4.1 PREGNANCY TEST KITS

14.3.4.2 NARCOTIC TEST KITS

14.3.4.3 HIV TEST KITS

14.3.4.4 FERTILITY TEST KITS

14.3.4.5 OTHER AT-HOME TEST KITS

15 INDONESIA AT-HOME TESTING KITS MARKET: COMPANY LANDSCAPE

15.1 COMPANY SHARE ANALYSIS: INDONESIA

16 SWOT ANALYSIS

17 COMPANY PROFILE

17.1 PT DANPAC PHARMA

17.1.1 COMPANY SNAPSHOT

17.1.2 PRODUCT PORTFOLIO

17.1.3 RECENT DEVELOPMENT

17.2 ABBOTT

17.2.1 COMPANY SNAPSHOT

17.2.2 REVENUS ANALYSIS

17.2.3 PRODUCT PORTFOLIO

17.2.4 RECENT DEVELOPMENT

17.3 ORIENT GENE

17.3.1 COMPANY SNAPSHOT

17.3.2 PRODUCT PORTFOLIO

17.3.3 RECENT DEVELOPMENT

17.4 SIEMENS HEALTHCARE GMBH

17.4.1 COMPANY SNAPSHOT

17.4.2 REVENUE ANALYSIS

17.4.3 PRODUCT PORTFOLIO

17.4.4 RECENT DEVELOPMENTS

17.5 MEDTRONIC

17.5.1 COMPANY SNAPSHOT

17.5.2 REVENUE ANALYSIS

17.5.3 PRODUCT PORTFOLIO

17.5.4 RECENT DEVELOPMENT

17.6 ACON LABORATORIES, INC.

17.6.1 COMPANY SNAPSHOT

17.6.2 PRODUCT PORTFOLIO

17.6.3 RECENT DEVELOPMENTS

17.7 B. BRAUN MELSUNGEN AG

17.7.1 COMPANY SNAPSHOT

17.7.2 PRODUCT PORTFOLIO

17.7.3 RECENT DEVELOPMENT

17.8 BD

17.8.1 COMPANY SNAPSHOT

17.8.2 REVENUS ANALYSIS

17.8.3 PRODUCT PORTFOLIO

17.8.4 RECENT DEVELOPMENTS

17.9 BIOMERIEUX

17.9.1 COMPANY SNAPSHOT

17.9.2 REVENUS ANALYSIS

17.9.3 PRODUCT PORTFOLIO

17.9.4 RECENT DEVELOPMENT

17.1 CLEARBLUE (A SUBSIDIARY OF SWISS PRECISION DIAGNOSTICS GMBH)

17.10.1 COMPANY SNAPSHOT

17.10.2 PRODUCT PORTFOLIO

17.10.3 RECENT DEVELOPMENTS

17.11 DKT INTERNATIONAL

17.11.1 COMPANY SNAPSHOT

17.11.2 PRODUCT PORTFOLIO

17.11.3 RECENT DEVELOPMENT

17.12 EGENS GROUP

17.12.1 COMPANY SNAPSHOT

17.12.2 PRODUCT PORTFOLIO

17.12.3 RECENT DEVELOPMENT

17.13 F. HOFFMANN- LA ROCHE LTD

17.13.1 COMPANY SNAPSHOT

17.13.2 REVENUS ANALYSIS

17.13.3 PRODUCT PORTFOLIO

17.13.4 RECENT DEVELOPMENT

17.14 NIPRO

17.14.1 COMPANY SNAPSHOT

17.14.2 REVENUE ANALYSIS

17.14.3 PRODUCT PORTFOLIO

17.14.4 RECENT DEVELOPMENT

17.15 QUIDEL CORPORATION

17.15.1 COMPANY SNAPSHOT

17.15.2 REVENUE ANALYSIS

17.15.3 PRODUCT PORTFOLIO

17.15.4 RECENT DEVELOPMENTS

18 QUESTIONNAIRE

19 RELATED REPORTS

표 목록

TABLE 1 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR PREGNANCY TEST KITS , BY PLAYERS (IDR MILLION, 2021)

TABLE 2 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR NARCOTICS TEST KITS , BY PLAYERS (IDR MILLION, 2021)

TABLE 3 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR HIV TEST KITS , BY PLAYERS (IDR MILLION, 2021)

TABLE 4 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR FERTILITY TEST KITS , BY PLAYERS (IDR MILLION, 2021)

TABLE 5 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR PREGNANCY TEST KITS , BY PLAYERS (IDR MILLION, 2022)

TABLE 6 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR NARCOTICS TEST KITS , BY PLAYERS (IDR MILLION, 2022)

TABLE 7 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR HIV TEST KITS , BY PLAYERS (IDR MILLION, 2022)

TABLE 8 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR FERTILITY TEST KITS , BY PLAYERS (IDR MILLION, 2022)

TABLE 9 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR PREGNANCY TEST KITS , BY PLAYERS (IDR MILLION, 2023)

TABLE 10 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR NARCOTICS TEST KITS , BY PLAYERS (IDR MILLION, 2023)

TABLE 11 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR HIV TEST KITS , BY PLAYERS (IDR MILLION, 2023)

TABLE 12 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR FERTILITY TEST KITS , BY PLAYERS (IDR MILLION, 2023)

TABLE 13 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR PREGNANCY TEST KITS , BY PLAYERS (IDR MILLION, 2024)

TABLE 14 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR NARCOTICS TEST KITS , BY PLAYERS (IDR MILLION, 2024)

TABLE 15 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR HIV TEST KITS , BY PLAYERS (IDR MILLION, 2024)

TABLE 16 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR FERTILITY TEST KITS , BY PLAYERS (IDR MILLION, 2024)

TABLE 17 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR PREGNANCY TEST KITS , BY PLAYERS (IDR MILLION, 2025)

TABLE 18 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR NARCOTICS TEST KITS , BY PLAYERS (IDR MILLION, 2025)

TABLE 19 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR HIV TEST KITS , BY PLAYERS (IDR MILLION, 2025)

TABLE 20 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR FERTILITY TEST KITS , BY PLAYERS (IDR MILLION, 2025)

TABLE 21 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR PREGNANCY TEST KITS , BY PLAYERS (IDR MILLION, 2026)

TABLE 22 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR NARCOTICS TEST KITS , BY PLAYERS (IDR MILLION, 2026)

TABLE 23 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR HIV TEST KITS , BY PLAYERS (IDR MILLION, 2026)

TABLE 24 INDONESIA AT-HOME TESTING KITS MARKET SHARE FOR FERTILITY TEST KITS , BY PLAYERS (IDR MILLION, 2026)

TABLE 25 INDONESIA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (IDR MILLION)

TABLE 26 INDONESIA AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (UNITS)

TABLE 27 INDONESIA PREGNANCY TEST KITS IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (IDR MILLION)

TABLE 28 INDONESIA NARCOTIC TEST KITS IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (IDR MILLION)

TABLE 29 INDONESIA HIV TEST KITS IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (IDR MILLION)

TABLE 30 INDONESIA FERTILITY TEST KITS IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (IDR MILLION)

TABLE 31 INDONESIA OTHER AT-HOME TEST KITS IN AT-HOME TESTING KITS MARKET, BY TEST TYPE, 2020-2029 (IDR MILLION)

TABLE 32 INDONESIA AT-HOME TESTING KITS MARKET, BY TYPE OF USER, 2020-2029 (IDR MILLION)

TABLE 33 INDONESIA MIDDLE CLASS IN AT-HOME TESTING KITS MARKET, BY TYPE OF USER, 2020-2029 (IDR MILLION)

TABLE 34 INDONESIA HIGH CLASS IN AT-HOME TESTING KITS MARKET, BY TYPE OF USER, 2020-2029 (IDR MILLION)

TABLE 35 INDONESIA LOW CLASS IN AT-HOME TESTING KITS MARKET, BY TYPE OF USER, 2020-2029 (IDR MILLION)

TABLE 36 INDONESIA AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)

TABLE 37 INDONESIA PREGNANCY TEST KITS IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)

TABLE 38 INDONESIA GOVERNMENT/INSTITUTIONAL IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)

TABLE 39 INDONESIA RETAIL/BRANDED IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)

TABLE 40 INDONESIA NARCOTIC TEST KITS IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)

TABLE 41 INDONESIA GOVERNMENT/INSTITUTIONAL IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)

TABLE 42 INDONESIA RETAIL/BRANDED IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)

TABLE 43 INDONESIA HIV TEST KITS IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)

TABLE 44 INDONESIA GOVERNMENT/INSTITUTIONAL IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)

TABLE 45 INDONESIA RETAIL/BRANDED IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)

TABLE 46 INDONESIA FERTILITY TEST KITS IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)

TABLE 47 INDONESIA GOVERNMENT/INSTITUTIONAL IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)

TABLE 48 INDONESIA RETAIL/BRANDED IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)

TABLE 49 INDONESIA OTHER AT-HOME TEST KITS IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)

TABLE 50 INDONESIA GOVERNMENT/INSTITUTIONAL IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)

TABLE 51 INDONESIA RETAIL/BRANDED IN AT-HOME TESTING KITS MARKET, BY TYPE OF BUYER, 2020-2029 (IDR MILLION)

TABLE 52 INDONESIA AT-HOME TESTING KITS MARKET, BY PROCESS LOCATION, 2020-2029 (IDR MILLION)

TABLE 53 INDONESIA AT-HOME LAB TESTS (DIGITAL RESULT) IN AT-HOME TESTING KITS MARKET, BY PROCESS LOCATION, 2020-2029 (IDR MILLION)

TABLE 54 INDONESIA AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (IDR MILLION)

TABLE 55 INDONESIA ADULT IN AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (IDR MILLION)

TABLE 56 INDONESIA GERIATRIC IN AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (IDR MILLION)

TABLE 57 INDONESIA PEDIATRIC IN AT-HOME TESTING KITS MARKET, BY AGE, 2020-2029 (IDR MILLION)

TABLE 58 INDONESIA AT-HOME TESTING KITS MARKET, BY BRANDS, 2020-2029 (IDR MILLION)

TABLE 59 INDONESIA PREGNANCY TEST IN AT-HOME TESTING KITS MARKET, BY BRANDS, 2020-2029 (IDR MILLION)

TABLE 60 INDONESIA NARCOTIC TEST IN AT-HOME TESTING KITS MARKET, BY BRANDS, 2020-2029 (IDR MILLION)

TABLE 61 INDONESIA HIV TEST IN AT-HOME TESTING KITS MARKET, BY BRANDS, 2020-2029 (IDR MILLION)

TABLE 62 INDONESIA FERTILITY TEST IN AT-HOME TESTING KITS MARKET, BY BRANDS, 2020-2029 (IDR MILLION)

TABLE 63 INDONESIA AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (IDR MILLION)

TABLE 64 INDONESIA INSTITUTIONAL BUYER IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (IDR MILLION)

TABLE 65 INDONESIA RETAILS/ BRANDED SALES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (IDR MILLION)

TABLE 66 INDONESIA RETAILS PHARMACIES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (IDR MILLION)

TABLE 67 INDONESIA ONLINE PHARMACIES IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (IDR MILLION)

TABLE 68 INDONESIA DRUG STORE IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (IDR MILLION)

TABLE 69 INDONESIA SUPERMARKET/HYPERMARKET IN AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (IDR MILLION)

그림 목록

FIGURE 1 INDONESIA AT-HOME TESTING KITS MARKET: SEGMENTATION

FIGURE 2 INDONESIA AT-HOME TESTING KITS MARKET: DATA TRIANGULATION

FIGURE 3 INDONESIA AT-HOME TESTING KITS MARKET: DROC ANALYSIS

FIGURE 4 INDONESIA AT-HOME TESTING KITS MARKET: COUNTRY VS REGIONAL MARKET ANALYSIS

FIGURE 5 INDONESIA AT-HOME TESTING KITS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 INDONESIA AT-HOME TESTING KITS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 INDONESIA AT-HOME TESTING KITS MARKET: MARKET TYPE OF BUYER COVERAGE GRID

FIGURE 8 INDONESIA AT-HOME TESTING KITS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 INDONESIA AT-HOME TESTING KITS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 INDONESIA AT-HOME TESTING KITS MARKET: SEGMENTATION

FIGURE 11 GROWING ADOPTION OF SELF-TESTING KITS AND EASY AVAILABILITY IS EXPECTED TO DRIVE INDONESIA AT-HOME TESTING KITS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 PREGNANCY TEST KITS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF INDONESIA AT-HOME TESTING KITS MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF INDONESIA AT-HOME TESTING KITS MARKET

FIGURE 14 INDONESIA AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2021

FIGURE 15 INDONESIA AT-HOME TESTING KITS MARKET: BY TEST TYPE, 2022-2029 (IDR MILLION)

FIGURE 16 INDONESIA AT-HOME TESTING KITS MARKET: BY TEST TYPE, CAGR (2022-2029)

FIGURE 17 INDONESIA AT-HOME TESTING KITS MARKET: BY TEST TYPE, LIFELINE CURVE

FIGURE 18 INDONESIA AT-HOME TESTING KITS MARKET: BY TYPE OF USER, 2021

FIGURE 19 INDONESIA AT-HOME TESTING KITS MARKET: BY TYPE OF USER, 2022-2029 (IDR MILLION)

FIGURE 20 INDONESIA AT-HOME TESTING KITS MARKET: BY TYPE OF USER, CAGR (2022-2029)

FIGURE 21 INDONESIA AT-HOME TESTING KITS MARKET: BY TYPE OF USER, LIFELINE CURVE

FIGURE 22 INDONESIA AT-HOME TESTING KITS MARKET: BY TYPE OF BUYER, 2021

FIGURE 23 INDONESIA AT-HOME TESTING KITS MARKET: BY TYPE OF BUYER, 2022-2029 (IDR MILLION)

FIGURE 24 INDONESIA AT-HOME TESTING KITS MARKET: BY TYPE OF BUYER, CAGR (2022-2029)

FIGURE 25 INDONESIA AT-HOME TESTING KITS MARKET: BY TYPE OF BUYER, LIFELINE CURVE

FIGURE 26 INDONESIA AT-HOME TESTING KITS MARKET: BY PROCESS LOCATION, 2021

FIGURE 27 INDONESIA AT-HOME TESTING KITS MARKET: BY PROCESS LOCATION, 2022-2029 (IDR MILLION)

FIGURE 28 INDONESIA AT-HOME TESTING KITS MARKET: BY PROCESS LOCATION, CAGR (2022-2029)

FIGURE 29 INDONESIA AT-HOME TESTING KITS MARKET: BY PROCESS LOCATION, LIFELINE CURVE

FIGURE 30 INDONESIA AT-HOME TESTING KITS MARKET: BY AGE, 2021

FIGURE 31 INDONESIA AT-HOME TESTING KITS MARKET: BY AGE, 2022-2029 (IDR MILLION)

FIGURE 32 INDONESIA AT-HOME TESTING KITS MARKET: BY AGE, CAGR (2022-2029)

FIGURE 33 INDONESIA AT-HOME TESTING KITS MARKET: BY AGE, LIFELINE CURVE

FIGURE 34 INDONESIA AT-HOME TESTING KITS MARKET: BY BRANDS, 2021

FIGURE 35 INDONESIA AT-HOME TESTING KITS MARKET: BY BRANDS, 2022-2029 (IDR MILLION)

FIGURE 36 INDONESIA AT-HOME TESTING KITS MARKET: BY BRANDS, CAGR (2022-2029)

FIGURE 37 INDONESIA AT-HOME TESTING KITS MARKET: BY BRANDS, LIFELINE CURVE

FIGURE 38 INDONESIA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 39 INDONESIA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (IDR MILLION)

FIGURE 40 INDONESIA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 41 INDONESIA AT-HOME TESTING KITS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 42 INDONESIA AT-HOME TESTING KITS MARKET: COMPANY SHARE 2021 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

Indonesia At-Home Testing Kits Market to grow at a CAGR 4.6% by forecast 2029.
Indonesia At-Home Testing Kits Market value to reach IDR 16, 81,367.36 million by forecast 2029.
Indonesia region holds the largest share in the market.
Major players operating in the at-home testing kits market are Abbott, PT. Danpac Pharma, Orient Gene, Siemens Healthcare GmbH, Medtronic, BD, B. Braun Melsungen AG, Quidel Corporation, NIPRO, F. Hoffmann-La Roche Ltd., bioMérieux SA, EGENS GROUP, DKT INTERNATIONAL, Clearblue (A subsidiary of SPD Swiss Precision Diagnostics GmbH), and ACON Laboratories, Inc.